Cellular bioterrorism: How Brucella corrupts macrophage physiology to promote invasion and proliferation

Clinical Immunology

Volumn 114, Issue 3 SPEC. ISS., 2005, Pages 227-238

  Maria Pilar, Jimenez De Bagues ^a   Dudal, Sherri ^b   Dornand, Jacques ^b   Gross, Antoine ^b  

^a Instituto Agroalimentario de Aragón IA2   (Spain)

^b INSERM   (France)

Author keywords

Bioterrorism; Brucella; Proliferation

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DOXYCYCLINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; POLYMYXIN B; RIFAMPICIN; RIMONABANT; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

APOPTOSIS; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BIOLOGICAL WARFARE; BRUCELLA; BRUCELLOSIS; CELLULAR IMMUNITY; CYTOKINE RELEASE; DRUG EFFECT; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; LIPID RAFT; MACROPHAGE FUNCTION; NONHUMAN; PHAGOCYTOSIS; PHAGOLYSOSOME; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 13844272287     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.07.010     Document Type: Article

References (94)

1. B. Robinson-Dunn The microbiology laboratory's role in response to bioterrorism Arch. Pathol. Lab. Med. 126 2002 291 294
2. T.A. Ficht Intracellular survival of Brucella: defining the link with persistence Vet. Microbiol. 92 2003 213 223
3. M.L. Boschiroli, S. Ouahrani-Bettache, V. Foulongne, S. Michaux-Charachon, G. Bourg, A. Allardet-Servent, C. Cazevieille, J.P. Lavigne, J.P. Liautard, M. Ramuz, and D. O'Callaghan Type IV secretion and Brucella virulence Vet. Microbiol. 90 2002 341 348
4. M. Refai Incidence and control of brucellosis in the Near East region Vet. Microbiol. 90 2002 81 110
5. J. Ariza, J. Corredoira, R. Pallares, P.F. Viladrich, G. Rufi, M. Pujol, and F. Gudiol Characteristics of and risk factors for relapse of brucellosis in humans Clin. Infect. Dis. 20 1995 1241 1249
6. A. Rahman, O. Burma, S. Felek, and H. Yekeler Atrial septal defect presenting with Brucella endocarditis Scand. J. Infect. Dis. 33 2001 776 777
7. Y. Zhan, A. Kelso, and C. Cheers Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts Infect. Immun. 63 1995 969 975
8. C.L. Baldwin, and M. Parent Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection Vet. Microbiol. 90 2002 367 382
9. S.C. Oliveira, and G.A. Splitter CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice Eur. J. Immunol. 25 1995 2551 2557
10. D.M. Fernandes, R. Benson, and C.L. Baldwin Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice Infect. Immun. 63 1995 4029 4033
11. J. Dornand, A. Gross, V. Lafont, J. Liautard, J. Oliaro, and J.P. Liautard The innate immune response against Brucella in humans Vet. Microbiol. 90 2002 383 394
12. M. Rodriguez-Zapata, M. Alvarez-Mon, I. Salmeron, A. Prieto, L. Manzano, O.J. Salmeron, and J. Carballido Diminished T lymphocyte proliferative response to polyclonal mitogens in acute brucellosis patients Infection 24 1996 115 120
13. M. Rodriguez-Zapata, I. Salmeron, L. Manzano, O.J. Salmeron, A. Prieto, and M. Alvarez-Mon Defective interferon-gamma production by T-lymphocytes from patients with acute brucellosis Eur. J. Clin. Invest. 26 1996 136 140
14. G.H. Giambartolomei, M.V. Delpino, M.E. Cahanovich, J.C. Wallach, P.C. Baldi, C.A. Velikovsky, and C.A. Fossati Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis J. Infect. Dis. 186 2002 252 259
15. M.C. Moreno-Lafont, R. Lopez-Santiago, E. Zumaran-Cuellar, V. Paredes-Cervantes, A. Lopez-Merino, A. Estrada-Aguilera, and L. Santos-Argumedo Antigen-specific activation and proliferation of CD4+ and CD8+ T lymphocytes from brucellosis patients Trans. R. Soc. Trop. Med. Hyg. 96 2002 340 347
16. A. Bertotto, R. Gerli, F. Spinozzi, C. Muscat, F. Scalise, G. Castellucci, M. Sposito, F. Candio, and R. Vaccaro Lymphocytes bearing the gamma delta T cell receptor in acute Brucella melitensis infection Eur. J. Immunol. 23 1993 1177 1180
17. F. Dieli, M. Troye-Blomberg, S.E. Farouk, G. Sirecil, and A. Salerno Biology of gammadelta T cells in tuberculosis and malaria Curr. Mol. Med. 1 2001 437 446
18. F. Poccia, M.L. Gougeon, C. Agrati, C. Montesano, F. Martini, C.D. Pauza, P. Fisch, M. Wallace, and M. Malkovsky Innate T-cell immunity in HIV infection: the role of Vgamma9Vdelta2 T lymphocytes Curr. Mol. Med. 2 2002 769 781
19. M.K. Oyoshi, H. Nagata, N. Kimura, Y. Zhang, A. Demachi, T. Hara, H. Kanegane, Y. Matsuo, T. Yamaguchi, T. Morio, A. Hirano, N. Shimizu, and K. Yamamoto Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection Am. J. Pathol. 162 2003 1629 1638
20. C.S. Subauste, J.Y. Chung, D. Do, A.H. Koniaris, C.A. Hunter, J.G. Montoya, S. Porcelli, and J.S. Remington Preferential activation and expansion of human peripheral blood gamma delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotoxic activity against T. gondii-infected cells J. Clin. Invest. 96 1995 610 619
21. F. Jouen-Beades, E. Paris, C. Dieulois, J.F. Lemeland, V. Barre-Dezelus, S. Marret, G. Humbert, J. Leroy, and F. Tron In vivo and in vitro activation and expansion of gammadelta T cells during Listeria monocytogenes infection in humans Infect. Immun. 65 1997 4267 4272
22. V. Lafont, J. Liautard, A. Gross, J.P. Liautard, and J. Favero Tumor necrosis factor-alpha production is differently regulated in gamma delta and alpha beta human T lymphocytes J. Biol. Chem. 275 2000 19282 19287
23. V. Lafont, S. Loisel, J. Liautard, S. Dudal, M. Sable-Teychene, J.P. Liautard, and J. Favero Specific signaling pathways triggered by IL-2 in human Vgamma9Vdelta2 T cells: an amalgamation of NK and alphabeta T cell signaling J. Immunol. 171 2003 5225 5232
24. F. Ottones, J. Liautard, A. Gross, F. Rabenoelina, J.P. Liautard, and J. Favero Activation of human Vgamma9Vdelta2 T cells by a Brucella suis non-peptidic fraction impairs bacterial intracellular multiplication in monocytic infected cells Immunology 100 2000 252 258
25. F. Ottones, J. Dornand, A. Naroeni, J.P. Liautard, and J. Favero V gamma 9V delta 2 T cells impair intracellular multiplication of Brucella suis in autologous monocytes through soluble factor release and contact-dependent cytotoxic effect J. Immunol. 165 2000 7133 7139
26. J.P. Gorvel, and E. Moreno Brucella intracellular life: from invasion to intracellular replication Vet. Microbiol. 90 2002 281 297
27. D. O'Callaghan, C. Cazevieille, A. Allardet-Servent, M.L. Boschiroli, G. Bourg, V. Foulongne, P. Frutos, Y. Kulakov, and M. Ramuz A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis Mol. Microbiol. 33 1999 1210 1220
28. V.T. Lee, and O. Schneewind Type III secretion machines and the pathogenesis of enteric infections caused by Yersinia and Salmonella spp Immunol. Rev. 168 1999 241 255
29. K. Ruckdeschel, S. Harb, A. Roggenkamp, M. Hornef, R. Zumbihl, S. Kohler, J. Heesemann, and B. Rouot Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production J. Exp. Med. 187 1998 1069 1079
30. K. Ruckdeschel, J. Machold, A. Roggenkamp, S. Schubert, J. Pierre, R. Zumbihl, J.P. Liautard, J. Heesemann, and B. Rouot Yersinia enterocolitica promotes deactivation of macrophage mitogen-activated protein kinases extracellular signal-regulated kinase-1/2, p38, and c-Jun NH2-terminal kinase. Correlation with its inhibitory effect on tumor necrosis factor-alpha production J. Biol. Chem. 272 1997 15920 15927
31. S. Kohler, V. Foulongne, S. Ouahrani-Bettache, G. Bourg, J. Teyssier, M. Ramuz, and J.P. Liautard The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell Proc. Natl. Acad. Sci. U. S. A. 99 2002 15711 15716
32. S. Kohler, S. Michaux-Charachon, F. Porte, M. Ramuz, and J.P. Liautard What is the nature of the replicative niche of a stealthy bug named Brucella? Trends Microbiol. 11 2003 215 219
33. J.P. Liautard, A. Gross, J. Dornand, and S. Kohler Interactions between professional phagocytes and Brucella spp Microbiologia 12 1996 197 206
34. C.M. Fernandez-Prada, E.B. Zelazowska, M. Nikolich, T.L. Hadfield, R.M. Roop II, G.L. Robertson, and D.L. Hoover Interactions between Brucella melitensis and human phagocytes: bacterial surface O-Polysaccharide inhibits phagocytosis, bacterial killing, and subsequent host cell apoptosis Infect. Immun. 71 2003 2110 2119
35. M.G. Rittig, A. Kaufmann, A. Robins, B. Shaw, H. Sprenger, D. Gemsa, V. Foulongne, B. Rouot, and J. Dornand Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes J. Leukocyte Biol. 74 2003 1045 1055
36. A. Naroeni, and F. Porte Role of cholesterol and the ganglioside GM(1) in entry and short-term survival of Brucella suis in murine macrophages Infect. Immun. 70 2002 1640 1644
37. F. Porte, A. Naroeni, S. Ouahrani-Bettache, and J.P. Liautard Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages Infect. Immun. 71 2003 1481 1490
38. M. Watarai, S. Kim, J. Erdenebaatar, S. Makino, M. Horiuchi, T. Shirahata, S. Sakaguchi, and S. Katamine Cellular prion protein promotes Brucella infection into macrophages J. Exp. Med. 198 2003 5 17
39. G. Martinez de Tejada, J. Pizarro-Cerda, E. Moreno, and I. Moriyon The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides Infect. Immun. 63 1995 3054 3061
40. F. Porte, J.P. Liautard, and S. Kohler Early acidification of phagosomes containing Brucella suis is essential for intracellular survival in murine macrophages Infect. Immun. 67 1999 4041 4047
41. V. Foulongne, G. Bourg, C. Cazevieille, S. Michaux-Charachon, and D. O'Callaghan Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis Infect. Immun. 68 2000 1297 1303
42. M.L. Boschiroli, S. Ouahrani-Bettache, V. Foulongne, S. Michaux-Charachon, G. Bourg, A. Allardet-Servent, C. Cazevieille, J.P. Liautard, M. Ramuz, and D. O'Callaghan The Brucella suis virB operon is induced intracellularly in macrophages Proc. Natl. Acad. Sci. U. S. A. 99 2002 1544 1549
43. A. Naroeni, N. Jouy, S. Ouahrani-Bettache, J.P. Liautard, and F. Porte Brucella suis-impaired specific recognition of phagosomes by lysosomes due to phagosomal membrane modifications Infect. Immun. 69 2001 486 493
44. J. Celli, C. de Chastellier, D.M. Franchini, J. Pizarro-Cerda, E. Moreno, and J.P. Gorvel Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum J. Exp. Med. 198 2003 545 556
45. M. Watarai, S. Makino, Y. Fujii, K. Okamoto, and T. Shirahata Modulation of Brucella-induced macropinocytosis by lipid rafts mediates intracellular replication Cell. Microbiol. 4 2002 341 355
46. E. Caron, T. Peyrard, S. Kohler, S. Cabane, J.P. Liautard, and J. Dornand Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes Infect. Immun. 62 1994 5267 5274
47. E. Caron, A. Gross, J.P. Liautard, and J. Dornand Brucella species release a specific, protease-sensitive, inhibitor of TNF-alpha expression, active on human macrophage-like cells J. Immunol. 156 1996 2885 2893
48. A. Gross, S. Spiesser, A. Terraza, B. Rouot, E. Caron, and J. Dornand Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages Infect. Immun. 66 1998 1309 1316
49. Y. Zhan, and C. Cheers Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors J. Immunol. 161 1998 1447 1453
50. A. Caballero, M.J. Bravo, A. Nieto, J.D. Colmenero, A. Alonso, and J. Martin TNFA promoter polymorphism and susceptibility to brucellosis Clin. Exp. Immunol. 121 2000 480 483
51. A. Gross, A. Terraza, S. Ouahrani-Bettache, J.P. Liautard, and J. Dornand In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells Infect. Immun. 68 2000 342 351
52. E. Galdiero, C. Romano Carratelli, M. Vitiello, I. Nuzzo, E. Del Vecchio, C. Bentivoglio, G. Perillo, and F. Galdiero HSP and apoptosis in leukocytes from infected or vaccinated animals by Brucella abortus New Microbiol. 23 2000 271
53. M. Tolomeo, P. Di Carlo, V. Abbadessa, L. Titone, S. Miceli, E. Barbusca, G. Cannizzo, S. Mancuso, S. Arista, and F. Scarlata Monocyte and lymphocyte apoptosis resistance in acute and chronic brucellosis and its possible implications in clinical management Clin. Infect. Dis. 36 2003 1533 1538
54. J.E. Ugalde, D.J. Comerci, M.S. Leguizamon, and R.A. Ugalde Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine Infect. Immun. 71 2003 6264 6269
55. M. Caroff, D.R. Bundle, M.B. Perry, J.W. Cherwonogrodzky, and J.R. Duncan Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3 Infect. Immun. 46 1984 384 388
56. F. Godfroid, B. Taminiau, I. Danese, P. Denoel, A. Tibor, V. Weynants, A. Cloeckaert, J. Godfroid, and J.J. Letesson Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages Infect. Immun. 66 1998 5485 5493
57. J.R. McQuiston, R. Vemulapalli, T.J. Inzana, G.G. Schurig, N. Sriranganathan, D. Fritzinger, T.L. Hadfield, R.A. Warren, L.E. Lindler, N. Snellings, D. Hoover, S.M. Halling, and S.M. Boyle Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence Infect. Immun. 67 1999 3830 3835
58. E. Freer, E. Moreno, I. Moriyon, J. Pizarro-Cerda, A. Weintraub, and J.P. Gorvel Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts J. Bacteriol. 178 1996 5867 5876
59. C.A. Allen, L.G. Adams, and T.A. Ficht Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival Infect. Immun. 66 1998 1008 1016
60. F.C. Eisenschenk, J.J. Houle, and E.M. Hoffmann Mechanism of serum resistance among Brucella abortus isolates Vet. Microbiol. 68 1999 235 244
61. E. Freer, J. Pizarro-Cerda, A. Weintraub, J.A. Bengoechea, I. Moriyon, K. Hultenby, J.P. Gorvel, and E. Moreno The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains Infect. Immun. 67 1999 6181 6186
62. S. Michaux-Charachon, G. Bourg, E. Jumas-Bilak, P. Guigue-Talet, A. Allardet-Servent, D. O'Callaghan, and M. Ramuz Genome structure and phylogeny in the genus Brucella J. Bacteriol. 179 1997 3244 3249
63. M.A. Campos, G.M. Rosinha, I.C. Almeida, X.S. Salgueiro, B.W. Jarvis, G.A. Splitter, N. Qureshi, O. Bruna-Romero, R.T. Gazzinelli, and S.C. Oliveira Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice Infect. Immun. 72 2004 176 186
64. M.G. Rittig, M.T. Alvarez-Martinez, F. Porte, J.P. Liautard, and B. Rouot Intracellular survival of Brucella spp. in human monocytes involves conventional uptake but special phagosomes Infect. Immun. 69 2001 3995 4006
65. S. Manes, G. del Real, and A.C. Martinez Pathogens: raft hijackers Nat. Rev., Immunol. 3 2003 557 568
66. M. Desjardins ER-mediated phagocytosis: a new membrane for new functions Nat. Rev., Immunol. 3 2003 280 291
67. M.P. Jimenez de Bagues, A. Terraza, A. Gross, and J. Dornand Different responses of macrophages to smooth and rough Brucella spp.: relationship to virulence Infect. Immun. 72 2004 2429 2433
68. L. Chang, and M. Karin Mammalian MAP kinase signalling cascades Nature 410 2001 37 40
69. E.S. Van Amersfoort, T.J. Van Berkel, and J. Kuiper Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock Clin. Microbiol. Rev. 16 2003 379 414
70. D.M. Underhill Toll-like receptors: networking for success Eur. J. Immunol. 33 2003 1767 1775
71. J. Goldstein, T. Hoffman, C. Frasch, E.F. Lizzio, P.R. Beining, D. Hochstein, Y.L. Lee, R.D. Angus, and B. Golding Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines Infect. Immun. 60 1992 1385 1389
72. B.W. Jarvis, T.H. Harris, N. Qureshi, and G.A. Splitter Rough lipopolysaccharide from Brucella abortus and Escherichia coli differentially activates the same mitogen-activated protein kinase signaling pathways for tumor necrosis factor alpha in RAW 264.7 macrophage-like cells Infect. Immun. 70 2002 7165 7168
73. A. Cloeckaert, P. de Wergifosse, G. Dubray, and J.N. Limet Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay Infect. Immun. 58 1990 3980 3987
74. L.Y. Huang, J. Aliberti, C.A. Leifer, D.M. Segal, A. Sher, D.T. Golenbock, and B. Golding Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent J. Immunol. 171 2003 1441 1446
75. C. Forestier, F. Deleuil, N. Lapaque, E. Moreno, and J.P. Gorvel Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation J. Immunol. 165 2000 5202 5210
76. C. Forestier, E. Moreno, J. Pizarro-Cerda, and J.P. Gorvel Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study J. Immunol. 162 1999 6784 6791
77. C. Forestier, E. Moreno, S. Meresse, A. Phalipon, D. Olive, P. Sansonetti, and J.P. Gorvel Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes Infect. Immun. 67 1999 4048 4054
78. E. Murphy, G.T. Robertson, M. Parent, S.D. Hagius, R.M. Roop, P.H. Elzer, and C.L. Baldwin Major histocompatibility complex class I and II expression on macrophages containing a virulent strain of Brucella abortus measured using green fluorescent protein-expressing brucellae and flow cytometry FEMS Immunol. Med. Microbiol. 33 2002 191 200
79. A. Gross, A. Terraza, J. Marchant, M. Bouaboula, S. Ouahrani-Bettache, J.P. Liautard, P. Casellas, and J. Dornand A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis J. Leukocyte Biol. 67 2000 335 344
80. M. Bouaboula, N. Desnoyer, P. Carayon, T. Combes, and P. Casellas Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation Mol. Pharmacol. 55 1999 473 480
81. A. Gross, M. Bouaboula, P. Casellas, J.P. Liautard, and J. Dornand Subversion and utilization of the host cell cyclic adenosine 5′-monophosphate/protein kinase a pathway by Brucella during macrophage infection J. Immunol. 170 2003 5607 5614
82. C. Schwencke, M. Yamamoto, S. Okumura, Y. Toya, S.J. Kim, and Y. Ishikawa Compartmentation of cyclic adenosine 3′,5′-monophosphate signaling in caveolae Mol. Endocrinol. 13 1999 1061 1070
83. K.M. Torgersen, T. Vang, H. Abrahamsen, S. Yaqub, and K. Tasken Molecular mechanisms for protein kinase A-mediated modulation of immune function Cell. Signal. 14 2002 1 9
84. M. Triantafilou, and K. Triantafilou Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster Trends Immunol. 23 2002 301 304
85. M. Triantafilou, K. Miyake, D.T. Golenbock, and K. Triantafilou Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation J. Cell Sci. 115 2002 2603 2611
86. T. Kambayashi, R.P. Wallin, and H.G. Ljunggren cAMP-elevating agents suppress dendritic cell function J. Leukocyte Biol. 70 2001 903 910
87. A. von Knethen, and B. Brune Attenuation of macrophage apoptosis by the cAMP-signaling system Mol. Cell. Biochem. 212 2000 35 43
88. V. Jubier-Maurin, R.A. Boigegrain, A. Cloeckaert, A. Gross, M.T. Alvarez-Martinez, A. Terraza, J. Liautard, S. Kohler, B. Rouot, J. Dornand, and J.P. Liautard Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages Infect. Immun. 69 2001 4823 4830
89. E.H. Lee, and Y. Rikihisa Protein kinase A-mediated inhibition of gamma interferon-induced tyrosine phosphorylation of Janus kinases and latent cytoplasmic transcription factors in human monocytes by Ehrlichia chaffeensis Infect. Immun. 66 1998 2514 2520
90. L.M. Ting, A.C. Kim, A. Cattamanchi, and J.D. Ernst Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1 J. Immunol. 163 1999 3898 3906
91. G.M. Kammer The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response Immunol. Today 9 1988 222 229
92. D. Burzyn, C.C. Jancic, S. Zittermann, M.I. Keller Sarmiento, L. Fainboim, R.E. Rosenstein, and H.E. Chuluyan Decrease in cAMP levels modulates adhesion to fibronectin and immunostimulatory ability of human dendritic cells J. Leukocyte Biol. 72 2002 93 100
93. G. Strassmann, V. Patil-Koota, F. Finkelman, M. Fong, and T. Kambayashi Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2 J. Exp. Med. 180 1994 2365 2370
94. C. Locht Molecular aspects of Bordetella pertussis pathogenesis Int. Microbiol. 2 1999 137 144